NASDAQ: VRTXVertex Pharmaceuticals Inc Stock Ownership - Who owns Vertex Pharmaceuticals?
Insider buying vs selling
Have Vertex Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Kristen Ambrose | SVP Chief Accounting Officer | 2024-04-02 | 240 | $419.00 | $100.56kSell |
| Kristen Ambrose | SVP Chief Accounting Officer | 2024-04-01 | 225 | $418.10 | $94.07kSell |
| Ourania Tatsis | EVP Chief Reg. Quality Off. | 2024-02-26 | 354 | $425.70 | $150.70kSell |
| Kristen Ambrose | SVP Chief Accounting Officer | 2024-02-26 | 883 | $425.70 | $375.89kSell |
| Stuart A. Arbuckle | EVP COO | 2024-02-26 | 5,034 | $425.70 | $2.14MSell |
| Amit Sachdev | EVP Chief Patient Ext Af Off | 2024-02-26 | 3,004 | $425.70 | $1.28MSell |
| Edward Morrow Atkinson Iii | EVP Chief Technical Ops. Off. | 2024-02-26 | 883 | $425.70 | $375.89kSell |
| David Altshuler | EVP Global Research and CSO | 2024-02-26 | 4,239 | $425.70 | $1.80MSell |
| Edward Morrow Atkinson Iii | EVP Chief Technical Ops. Off. | 2024-02-23 | 1,654 | $431.79 | $714.18kSell |
| Charles F. Wagner Jr. | EVP Chief Financial Officer | 2024-02-23 | 3,309 | $431.79 | $1.43MSell |
VRTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when VRTX insiders and whales buy or sell their stock.
VRTX Shareholders
What type of owners hold Vertex Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 8.63% | 22,282,180 | $8.79B | Institution |
| Blackrock Inc | 8.47% | 21,881,203 | $8.63B | Institution |
| Capital World Investors | 8.44% | 21,805,770 | $8.60B | Institution |
| Fmr LLC | 5.02% | 12,979,511 | $5.12B | Institution |
| State Street Corp | 4.68% | 12,083,818 | $4.76B | Institution |
| Alliancebernstein LP | 2.73% | 7,039,738 | $2.78B | Institution |
| Price T Rowe Associates Inc | 2.28% | 5,887,412 | $2.32B | Institution |
| Geode Capital Management LLC | 2.20% | 5,673,419 | $2.24B | Institution |
| Jpmorgan Chase Co | 2.18% | 5,624,265 | $2.22B | Institution |
| Wellington Management Group LLP | 2.02% | 5,228,538 | $2.06B | Institution |
VRTX vs Biotech Stocks
Vertex Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.